PEDIATRIC NEUROLOGY, cilt.88, ss.71-74, 2018 (SCI-Expanded)
BACKGROUND: COQ2 mutations cause a rare infantile multisystemic disease with heterogeneous clinical features. Promising results have been reported in response to Coenzyme Q10 treatment, especially for kidney involvement, but little is known about the long-term outcomes.